These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12855769)

  • 1. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.
    Gu H; Roizman B
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8963-8. PubMed ID: 12855769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.
    Hagglund R; Van Sant C; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):631-6. PubMed ID: 11805320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.
    Gu H; Roizman B
    J Virol; 2009 Jan; 83(1):181-7. PubMed ID: 18945770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.
    Parkinson J; Everett RD
    J Virol; 2000 Nov; 74(21):10006-17. PubMed ID: 11024129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
    Zheng Y; Gu H
    J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
    Van Sant C; Hagglund R; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0.
    Hagglund R; Roizman B
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7889-94. PubMed ID: 12060736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.
    Boutell C; Sadis S; Everett RD
    J Virol; 2002 Jan; 76(2):841-50. PubMed ID: 11752173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).
    Vanni E; Gatherer D; Tong L; Everett RD; Boutell C
    J Virol; 2012 Jun; 86(11):6323-33. PubMed ID: 22438555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
    Lopez P; Jacob RJ; Roizman B
    J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.
    Mostafa HH; Thompson TW; Davido DJ
    J Virol; 2013 Feb; 87(4):2109-19. PubMed ID: 23221554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
    Boutell C; Orr A; Everett RD
    J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.
    Everett RD; Parada C; Gripon P; Sirma H; Orr A
    J Virol; 2008 Mar; 82(6):2661-72. PubMed ID: 18160441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.
    Boutell C; Canning M; Orr A; Everett RD
    J Virol; 2005 Oct; 79(19):12342-54. PubMed ID: 16160161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.
    Negorev DG; Vladimirova OV; Ivanov A; Rauscher F; Maul GG
    J Virol; 2006 Aug; 80(16):8019-29. PubMed ID: 16873258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity.
    Hagglund R; Roizman B
    J Virol; 2003 Dec; 77(24):13194-202. PubMed ID: 14645576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.